| US7285267B2 (en) | 1997-01-14 | 2007-10-23 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6α & 6β |
| CN1247567A (en) | 1997-01-14 | 2000-03-15 | 人体基因组科学有限公司 | Tumor necrosis factor receptor alfa 6 and receptor beta 6 |
| US7901693B2 (en) | 1998-09-30 | 2011-03-08 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7655249B2 (en) | 1998-09-30 | 2010-02-02 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7115272B1 (en) | 1998-09-30 | 2006-10-03 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7063854B1 (en) | 1998-09-30 | 2006-06-20 | Corixa Corporation | Composition and methods for WTI specific immunotherapy |
| US7144581B2 (en) | 2000-10-09 | 2006-12-05 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US7329410B1 (en) | 1998-09-30 | 2008-02-12 | Corixa Corporation | Compositions and method for WT1 specific immunotherapy |
| US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
| WO2004043361A2 (en)* | 2002-11-08 | 2004-05-27 | Genentech, Inc. | Compositions and methods for the treatment of natural killer cell related diseases |
| AU6531101A (en)* | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| KR100399982B1 (en)* | 2000-06-16 | 2003-11-13 | 학교법인고려중앙학원 | Novel mouse CIA protein and CIA gene having anti-apoptotic activity as a selective inhibitor of CAD interacting with ASK1 and use thereof |
| CN1329031A (en)* | 2000-06-19 | 2002-01-02 | 上海博德基因开发有限公司 | Polypeptide-human RNA bindin 19 and polynucleotide for coding it |
| EP1358339A2 (en)* | 2000-07-21 | 2003-11-05 | Millennium Pharmaceuticals, Inc. | 56939, a human acyl-coa thioesterase family member and uses thereof |
| WO2002036808A2 (en)* | 2000-11-03 | 2002-05-10 | Diadexus, Inc. | Compositions and methods relating to prostate specific genes and proteins |
| US7534429B2 (en) | 2000-11-29 | 2009-05-19 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| US7431923B2 (en) | 2005-01-03 | 2008-10-07 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| US7442777B2 (en) | 2000-11-29 | 2008-10-28 | Arius Research Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| JP2005506040A (en) | 2000-12-20 | 2005-03-03 | ブリストル−マイヤーズ スクイブ カンパニー | Polynucleotide encoding a novel human phosphatase |
| EP2280030A3 (en) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| CA2443617C (en)* | 2001-04-17 | 2013-12-10 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| US20030060410A1 (en)* | 2001-05-15 | 2003-03-27 | North Shore Long Island Jewish Research Institute | Use of HMG fragments as anti-inflammatory agents |
| IL159015A0 (en)* | 2001-05-25 | 2004-05-12 | Genset Sa | Polypeptides, their preparation and use |
| US7157558B2 (en)* | 2001-06-01 | 2007-01-02 | Genentech, Inc. | Polypeptide encoded by a polynucleotide overexpresses in tumors |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| WO2003004989A2 (en) | 2001-06-21 | 2003-01-16 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| WO2003010198A1 (en)* | 2001-07-26 | 2003-02-06 | Kenton Srl | Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| US7270960B2 (en)* | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| US7504222B2 (en)* | 2001-10-31 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US7306919B1 (en)* | 2001-10-31 | 2007-12-11 | Thornthwaite Jerry T | Antigen-antibody cancer recognition system |
| US20050095592A1 (en)* | 2002-02-13 | 2005-05-05 | Jazaeri Amir A. | Identification of ovarian cancer tumor markers and therapeutic targets |
| CN1507491A (en)* | 2002-02-19 | 2004-06-23 | 株式会社Bf研究所 | Apoptosis promoter and inhibitor interacting with CGI-94 and method of screening the same |
| CA2992643C (en) | 2002-03-13 | 2019-06-18 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
| AU2003233124A1 (en)* | 2002-04-29 | 2003-11-17 | Clinigenetics | Assays for identifying cholesterol - lowering molecules |
| US7563882B2 (en)* | 2002-06-10 | 2009-07-21 | University Of Rochester | Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| AU2003278137A1 (en) | 2002-06-20 | 2004-01-06 | Bristol-Myers Squibb Company | Identification and regulation of a g-protein coupled receptor, rai-3 |
| EP1576113A4 (en)* | 2002-07-03 | 2010-08-18 | Aventis Pasteur Inc | Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| WO2004005501A1 (en)* | 2002-07-08 | 2004-01-15 | Bayer Healthcare Ag | Regulation of human casein kinase i epsilon |
| EP1575500A4 (en) | 2002-07-12 | 2007-01-03 | Univ Johns Hopkins | MESOTHELIN VACCINES AND MODEL SYSTEMS |
| US20090110702A1 (en) | 2002-07-12 | 2009-04-30 | The Johns Hopkins University | Mesothelin Vaccines and Model Systems and Control of Tumors |
| US9200036B2 (en) | 2002-07-12 | 2015-12-01 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| AU2003258127A1 (en) | 2002-08-06 | 2004-02-23 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
| EP1537243B1 (en)* | 2002-08-30 | 2008-05-28 | Oncotherapy Science, Inc. | Method of diagnosing ovarian endometriosis |
| AU2002951346A0 (en)* | 2002-09-05 | 2002-09-26 | Garvan Institute Of Medical Research | Diagnosis of ovarian cancer |
| SI2891666T1 (en) | 2002-10-16 | 2017-11-30 | Purdue Pharma L.P. | Antibodies that bind cell-associated CA 125/O722P and methods of use thereof |
| CA2506066A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| EP1581641A4 (en)* | 2002-12-06 | 2006-11-15 | Diadexus Inc | Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| DK1597391T3 (en) | 2003-02-20 | 2009-01-12 | Genomic Health Inc | Use of intron RNA to measure gene expression |
| SI2248899T1 (en) | 2003-03-19 | 2015-07-31 | Biogen Ma Inc. | NOGO receptor binding protein |
| EP1641810B2 (en) | 2003-06-24 | 2017-04-19 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
| DK1644858T3 (en) | 2003-07-10 | 2018-01-22 | Genomic Health Inc | Functional clothing with at least one outer layer and inner membrane. |
| WO2005014818A1 (en) | 2003-08-08 | 2005-02-17 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| WO2005019258A2 (en)* | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US7799518B2 (en)* | 2003-10-07 | 2010-09-21 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| CA2445743A1 (en) | 2003-10-08 | 2005-04-08 | The University Of British Columbia | Methods for modulating neuronal responses |
| AU2004309396B2 (en) | 2003-12-23 | 2010-05-13 | Genomic Health, Inc. | Universal amplification of fragmented RNA |
| US7569662B2 (en) | 2004-01-27 | 2009-08-04 | Compugen Ltd | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer |
| US7667001B1 (en) | 2004-01-27 | 2010-02-23 | Compugen Ltd. | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer |
| EP1733743A4 (en)* | 2004-04-09 | 2007-06-27 | Takeda Pharmaceutical | PREVENTION AGENTS / REMEDIES AGAINST CANCER |
| EP2947160B1 (en) | 2004-04-09 | 2017-07-12 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| JP4960865B2 (en) | 2004-06-24 | 2012-06-27 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Treatment of conditions related to demyelination |
| US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
| EP1815014B1 (en) | 2004-11-05 | 2012-03-21 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| HUE051605T2 (en) | 2004-11-05 | 2021-03-01 | Nsabp Found Inc | Predicting response to chemotherapy using gene expression markers |
| EP1827454A4 (en)* | 2004-12-09 | 2008-07-16 | Brigham & Womens Hospital | KINASE-HASPIN BASED COMPOSITIONS AND METHODS |
| WO2006108095A2 (en)* | 2005-04-06 | 2006-10-12 | The University Of Maryland, Baltimore | Serum biomarker for disease and methods of using same |
| US20080292627A1 (en)* | 2005-05-05 | 2008-11-27 | The Board Of Trustees Of The University Of Illinois | Compositions and Methods for Treating Mood and Anxiety Disorders |
| EP1907013A4 (en)* | 2005-05-26 | 2009-12-23 | Univ Johns Hopkins | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CHEMOSTOROUS NEOPLASIA |
| US7439328B2 (en)* | 2005-07-01 | 2008-10-21 | Cornell Research Foundation, Inc. | Tctex-1-related polypeptides |
| CA2614421A1 (en) | 2005-07-08 | 2007-01-18 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
| RU2451521C2 (en) | 2006-06-16 | 2012-05-27 | Онкотерапи Сайенс, Инк. | Sparc-derivative antigenic peptides causing tumour rejection and medications containing such peptides |
| BRPI0717024A2 (en) | 2006-10-06 | 2014-03-11 | Takeda Pharmaceutical | ANTIBODY, HYBRIDOMA CELL, DIAGNOSTIC AGENT, MEDICINAL PRODUCT, METHODS TO PREVENT / TREAT CANCER, TO INDUCE APOPTOSIS CANCER CELLS, TO INHIBIT CANCER CELL GROWTH, AND FOR DESTROCULAR CANCULAR CIRCULAR MAMA. |
| US8128926B2 (en) | 2007-01-09 | 2012-03-06 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
| US7812002B2 (en)* | 2007-03-21 | 2010-10-12 | Quark Pharmaceuticals, Inc. | Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer |
| US8455189B2 (en)* | 2007-03-29 | 2013-06-04 | Jeffrey W. Allard | Use of HE4 for assessment of breast cancers |
| WO2008157383A1 (en)* | 2007-06-15 | 2008-12-24 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis of ovarian cancer and lung cancer |
| US20090125247A1 (en)* | 2007-08-16 | 2009-05-14 | Joffre Baker | Gene expression markers of recurrence risk in cancer patients after chemotherapy |
| WO2009048605A1 (en)* | 2007-10-11 | 2009-04-16 | Biogen Idec Ma Inc. | Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell, survival via administration of lingo-1 antagonists and trkb agonists |
| WO2009061500A1 (en)* | 2007-11-08 | 2009-05-14 | Biogen Idec Ma Inc. | Use of lingo-4 antagonists in the treatment of conditions involving demyelination |
| WO2009082485A1 (en) | 2007-12-26 | 2009-07-02 | Vaccinex, Inc. | Anti-c35 antibody combination therapies and methods |
| WO2009144704A2 (en)* | 2008-04-15 | 2009-12-03 | Quark Pharmaceuticals, Inc. | siRNA COMPOUNDS FOR INHIBITING NRF2 |
| US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
| CA2745849A1 (en)* | 2008-12-09 | 2010-06-17 | Alethia Biotherapeutics Inc. | Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| US20120087910A1 (en)* | 2009-03-11 | 2012-04-12 | Abraxis Bioscience, Llc | Sparc angiogenic domain and methods of use |
| WO2010124365A1 (en) | 2009-04-27 | 2010-11-04 | Ottawa Hospital Research Institute | Compositions and methods for modulating stem cells and uses thereof |
| US9220746B2 (en) | 2009-06-04 | 2015-12-29 | The University Of North Carolina At Chapel Hill | Compounds and methods for treating bone disorders and controlling weight |
| US9732130B2 (en) | 2011-09-16 | 2017-08-15 | Ottawa Hospital Research Institute | WNT7A compositions and method of using the same |
| SG11201400668SA (en)* | 2011-09-16 | 2014-04-28 | Fate Therapeutics Inc | Wnt compositions and therapeutic uses of such compositions |
| WO2013155567A1 (en)* | 2012-04-20 | 2013-10-24 | Mat Malta Advanced Technologies Limited | Sex determination genes |
| WO2013173364A2 (en) | 2012-05-14 | 2013-11-21 | Biogen Idec Ma Inc. | Lingo-2 antagonists for treatment of conditions involving motor neurons |
| US10364277B2 (en)* | 2013-07-01 | 2019-07-30 | Newsouth Innovations Pty Limited | Diagnosis and treatment of autoimmune diseases |
| PT3019619T (en) | 2013-07-11 | 2021-11-11 | Modernatx Inc | COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING SYNTHETIC CRISPR AND SGARN-RELATED PROTEINS AND METHODS OF USE |
| EP3112378B1 (en)* | 2014-02-26 | 2020-06-24 | Tella, Inc. | Wt1 antigenic polypeptide, and anti-tumor agent containing said polypeptide |
| AU2016205197B2 (en) | 2015-01-08 | 2021-10-21 | Biogen Ma Inc. | LINGO-1 antagonists and uses for treatment of demyelinating disorders |
| WO2017070569A1 (en)* | 2015-10-23 | 2017-04-27 | Oregon Health & Science University | Compounds that bind macrophage migration inhibitory factor |
| US11639371B2 (en)* | 2016-02-17 | 2023-05-02 | The Chinese University Of Hong Kong | Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| DE102018200518B4 (en)* | 2018-01-15 | 2023-09-14 | Robert Bosch Gmbh | Microfluidic device and method for its operation |
| EP4150079A1 (en) | 2020-05-15 | 2023-03-22 | Crispr Therapeutics AG | Messenger rna encoding cas9 for use in genome-editing systems |
| CN112557347B (en)* | 2020-11-12 | 2023-10-24 | 渤海大学 | Preparation and detection method of chyle particle migration model in mucus layer |
| GB202211117D0 (en)* | 2022-07-29 | 2022-09-14 | Replay Holdings Llc | Compositions and methods for non-immunogenecity |